Drug Type Induced pluripotent stem cells (iPSC) |
Synonyms |
Target |
Action modulators |
Mechanism CXCR4 modulators(C-X-C motif chemokine receptor 4 modulators), IL-10 modulators(Interleukin-10 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft Rejection | Preclinical | France | 01 Dec 2024 | |
Inflammatory Bowel Diseases | Preclinical | France | 01 Dec 2024 |